『Pharmaceutical Executive Daily: FDA Approves Breyanzi』のカバーアート

Pharmaceutical Executive Daily: FDA Approves Breyanzi

Pharmaceutical Executive Daily: FDA Approves Breyanzi

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

 In today’s Pharmaceutical Executive Daily, the FDA greenlights an expanded use of Breyanzi, Eli Lilly reports Jaypirca met its primary endpoint in a head-to-head Phase III trial against Imbruvica for CLL/SLL, and new analyses highlight how health systems are strengthening partnerships to support cell and gene therapy commercialization.
まだレビューはありません